


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+9.19%
+2.92%
-1.22%
+1.27%
SCYX
SCYNEXIS
$0.80
SCYX Price Performance
$0.61 (+31.15%)
$0.66 (+21.21%)
$0.89 (-10.11%)
$1.15 (-30.43%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
SCYX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SCYX Street Sentiment is extremely bullish and have negative views on the near-term outlook
SCYX has Medium risk level
Risks Indicators

Beta greater than 1.0

Price under $5

Average key support and resistance price levels
REGN
771.25
+1.13%
PFE
26.50
+2.40%
ITRM
0.34
+2.09%
INVA
19.72
+1.02%
SCYX
SCYNEXIS
0.80
+0.76%
QXO
QXO Inc.
23.63
-1.29%
AAP
Advance Auto Parts
49.34
+3.70%
RAPT
RAPT Therapeutics In
57.61
-0.02%
REGN
Regeneron Pharma
771.25
+1.13%
What is SCYX current stock price?
What are SCYX stock strengths?
What is SCYX Risk Level?
What is SCYX market cap and volume?
What is SCYX current Stock IQ?
Should I buy SCYX stock right now?
Is SCYX a Strong Buy right now?
What does a 'Strong Buy' rating mean for SCYX?
What does a 'Strong Sell' rating mean for SCYX?
What factors influence SCYX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+9.19%
+2.92%
-1.22%
+1.27%
SCYX
SCYNEXIS
Current Price
$0.80
Stock Insights
Not Enough Information
Linked to SCYX
REGN
771.25
+1.13%
PFE
26.50
+2.40%
ITRM
0.34
+2.09%
INVA
19.72
+1.02%
Recently Viewed
SCYX
SCYNEXIS
0.80
+0.76%
QXO
QXO Inc.
23.63
-1.29%
AAP
Advance Auto Parts
49.34
+3.70%
RAPT
RAPT Therapeutics In
57.61
-0.02%
REGN
Regeneron Pharma
771.25
+1.13%

SCYX Price Performance
$0.61 (+31.15%)
$0.66 (+21.21%)
$0.89 (-10.11%)
$1.15 (-30.43%)
SCYX Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
SCYX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SCYX Street Sentiment is extremely bullish and have negative views on the near-term outlook
SCYX has Medium risk level
Risks Indicators

Beta greater than 1.0

Price under $5

Average key support and resistance price levels
SCYX Stock IQ
SCYX Latest Analysis
SCYNEXIS Receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designations for SCY-247. The QIDP designation will ensure at least 10 years of market exclusivity for SCY-247 following approval
Wed Jan 21, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
SCYX Stock trends
SCYX Stock performance
SCYX Stock analysis
SCYX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.